000			02035 a2200553 4500
005			20250517005909.0
264		0	_c20151209
008			201512s 0 0 eng d
022			_a1557-3265
024	7		_a10.1158/1078-0432.CCR-13-3317 _2doi
040			_aNLM _beng _cNLM
100	1		_aWu, Lixian
245	0	0	_aDual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells. _h[electronic resource]
260			_bClinical cancer research : an official journal of the American Association for Cancer Research _cFeb 2015
300			_a833-43 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCurcumin _xanalogs & derivatives
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFusion Proteins, bcr-abl _xantagonists & inhibitors
650	0	4	_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aImmunoblotting
650	0	4	_aImmunoprecipitation
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xpathology
650	0	4	_aMice
650	0	4	_aMice, Inbred NOD
650	0	4	_aMice, SCID
650	0	4	_aNeoplastic Stem Cells _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aYu, Jing
700	1		_aChen, Ruijia
700	1		_aLiu, Yang
700	1		_aLou, Liguang
700	1		_aWu, Ying
700	1		_aHuang, Lisen
700	1		_aFan, Yingjuan
700	1		_aGao, Pinzhang
700	1		_aHuang, Meijuan
700	1		_aWu, Yong
700	1		_aChen, Yuanzhong
700	1		_aXu, Jianhua
773	0		_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 21 _gno. 4 _gp. 833-43
856	4	0	_uhttps://doi.org/10.1158/1078-0432.CCR-13-3317 _zAvailable from publisher's website
999			_c24453354 _d24453354